Set your patients up for success with the TAVALISSE Onboarding Kitprotecting platelets. defending patients.
Downloadable resources to help patients start and stay on track with TAVALISSE
These tools are designed to help educate patients on chronic immune thrombocytopenia (ITP) and what to expect from TAVALISSE treatment. They also provide tips for a successful start to therapy, information on copay assistance, and other useful guidance.
This brochure provides information on ITP, how TAVALISSE is different from other therapies, and how TAVALISSE can help patients reach their treatment goals.
This journal offers suggestions to help incorporate TAVALISSE into patients’ lifestyles, stay on track with treatment, and monitor progress.
Use the TAVALISSE Enrollment and Patient Assistance Program Form as a prescription and to enroll a patient into RIGEL ONECARE and the Patient Assistance Program, if eligible.
Provides information such as indication, dosing, safety, and efficacy, as approved by the FDA.
Reviews important information for patients about TAVALISSE, including for whom TAVALISSE is intended, how to take TAVALISSE, and what to expect while on treatment.
This poster explains the symptoms of ITP, how ITP is diagnosed, and next steps after diagnosis.